Åkerlund M et al. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 µg desogestrel and either 30 µg or 20 µg ethinyl oestradiol. Br J Obstet Gynaecol 1993; 100: 832–8
Endrikat J et al. Comparison of efficacy, cycle control and tolerability of two low-dose oral contraceptives in a multicenter clinical study. Contraception 1999; 60: 269–74
Fotherby K et al. Clinical experience and pharmacological effects of an oral contraceptive containing 20 µg oestrogen. Contraception 1992; 46: 477–88
Serfaty D et al. A comparison of the cycle control and tolerability of two ultra-low-dose oral contraceptives containing 20 µg ethinylestradiol and either 150 µg desogestrel or 75 µg gestodene. Eur J Contracept Reprod Health Care 1998; 3: 179–89
Ernst U et al. Improvement of quality of life in women using a low-dose desogestrel-containing contraceptive: results of an observational clinical evaluation. Eur J Contracept Reprod Health Care 2002;7(4):238-43
Egarter C et al. Low dose oral contraceptives and quality of life. Contraception 1999; 59: 287-91
Winkler et al. Cycle control, quality of life and acne with two low dose oral contraceptives containing 20 mcg ethinylestradiol. Contraception 2004; 69: 469-478
Lammers P et al. Phase III clinical trial with a new oral contraceptive containing 150 micrograms desogestrel and 20 micrograms ethinylestradiol. Acta Obstet Gynecol Scand 1991;70(6):497-500.
